ADRENAL
These adverse effects of platinum-based alkylating agents can lead to premature cessation of treatment
What are renal toxicity, ototoxicity, peripheral neuropathy, and bone marrow suppression?
High/prolonged fever after intravesical therapy with this agent may lead to a patient receiving treatment for something very different than originally intended
BCG (TB)
Extension into the perinephric fat during a [partial] nephrectomy buys you a course of this - as long as you have clear cell histology
Pembrolizumab
The four common adverse effects associated with cisplatin
Renal toxicity, ototoxicity, peripheral neuropathy, and bone marrow suppression
Fatigue, gynecomastia/breast tenderness, hot flashes, decreased libido, decreased bone density
This family of medications can be used to help manage the downstream effects of functional benign adrenal adenomas
Aldosterone antagonists (e.g. eplerenone, spironolactone)
An adenovirus vector-based gene therapy
Ipilimumab/Nivolumab
You can use these two drugs for non-invasive Tis or Ta disease
Imiquimod, 5-FU
Beware of this when giving your patients a certain GnRH agonist
Initial T flare (Leuprolide)
This anthracycline/topoisomerase inhibitor classically can cause cardiomyopathy and requires a baseline TTE
Gemcitabine's indication in renal malignancy
Pathologic staging of penile cancer invading into the corpora cavernosa
pT3
This anti-androgen may cause adrenal insufficiency - so make sure you give it with Prednisone
Abiraterone
Hydrocortisone, methylprednisolone
The mechanism of action of this systemic therapy that cause renal toxicity, tinnitus, and peripheral neuropathy
Platinum alkylating agent
Bevacizumab, Cabozantinib, and Sunitinib all target this
VEGF
It may cause hematuria - so maybe you want to give it to your patient with MESNA?
Ifosfamide
This out-of-the-box medication causes rapid depression of [T]
Ketoconazole
This medication is used to treat metastatic ACC
Mitotane
Hot off the press! The medication that binds this ligand is the new hottest thing in metastatic urothelial cancer.
The systemic therapy that may cause ocular toxicity that is indicated in VHL-associated RCC
Belzutifan
The mechanism of action of this medication used for recurrent or metastatic penile carcinoma that may be associated with black or tarry stools, neurotoxicity, and mouth ulcers
Microtubule inhibitor (Paclitaxel)
This autologous cellular immunotherapy can be used in certain patients with mCRPC
Sipuleucel-T